| Authors: |
Zhou X; Department of Bioengineering and Therapeutic Sciences, University of California, San Francisco, CA, USA., Azimi M; Department of Bioengineering and Therapeutic Sciences, University of California, San Francisco, CA, USA., Handin N; Department of Pharmacy, Uppsala University, Uppsala, Sweden., Riselli A; Department of Bioengineering and Therapeutic Sciences, University of California, San Francisco, CA, USA., Vora B; Department of Bioengineering and Therapeutic Sciences, University of California, San Francisco, CA, USA., Chun E; Department of Bioengineering and Therapeutic Sciences, University of California, San Francisco, CA, USA., Dang Z; Department of Bioengineering and Therapeutic Sciences, University of California, San Francisco, CA, USA., Huang E; Department of Pathology, University of California, San Francisco, CA, USA., Yee SW; Department of Bioengineering and Therapeutic Sciences, University of California, San Francisco, CA, USA., Artursson P; Department of Pharmacy, Uppsala University, Uppsala, Sweden., Giacomini KM; Department of Bioengineering and Therapeutic Sciences, University of California, San Francisco, CA, USA. Kathy.Giacomini@ucsf.edu. |
